Related Experiment Video
Updated: Jun 16, 2026
SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
Fast and automated functional classification with MED-SuMo: an application on purine-binding proteins
Olivia Doppelt-Azeroual1, François Delfaud, Fabrice Moriaud
1INSERM UMR-S 665, Dynamique des Structures et Interactions des Macromolécules Biologiques (DSIMB), Université Paris Diderot-Paris 7, Institut National de la Transfusion Sanguine (INTS), 6, rue Alexandre Cabanel, 75739 Paris cedex 15, France. olivia.doppelt@medit.fr
MED-SMA classifies protein binding sites using MED-SuMo technology and a similarity graph. This method groups proteins with similar binding mechanisms, aiding drug design and toxicity prediction.
Area of Science:
- Biochemistry
- Structural Biology
- Computational Biology
Background:
- Ligand-protein interactions are fundamental to biological processes.
- Accurate identification of protein binding sites is key to understanding protein function.
- Purine binding sites are significant targets in drug discovery.
Purpose of the Study:
- To classify purine binding sites within the Protein DataBank (PDB) using the MED-SMA method.
- To group proteins that are potentially modulated by the same mechanism.
- To demonstrate the utility of MED-SMA in drug design and predicting off-target effects.
Main Methods:
- Utilized MED-SuMo technology for 3D surface feature analysis of macromolecules.
- Employed MED-SMA, an automated method based on MED-SuMo, to build a similarity graph and cluster binding sites using Markov Clustering.
- Classified purine binding sites from the PDB and analyzed clusters against PROSITE and PDB functional annotations.
Main Results:
- Successfully classified purine binding sites, grouping proteins with similar binding mechanisms (e.g., Small GTPases).
- Identified clusters containing protein kinases from different families that share common inhibitors (e.g., Aurora-A, CDK2).
- Demonstrated that MED-SMA effectively groups binding sites with similar structure-activity relationships and introduced a protocol for classifying ligand-free structures.
Conclusions:
- MED-SMA is effective in classifying protein binding sites based on structural and chemical features.
- The classification facilitates the grouping of proteins with similar biological mechanisms and drug responses.
- This approach supports target-based drug design, prediction of cross-reactivity, and identification of potential toxic side effects.
